Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
暂无分享,去创建一个
H. Wallerand | J. Thiery | F. Radvanyi | Z. Wainberg | Ying Cai | I. Garraway | I. Lascombe | H. Bittard | Robert R Reiter | G. Nicolle
[1] M. Loda,et al. Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors , 2007, Clinical Cancer Research.
[2] H. Wallerand,et al. Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation , 2006, Clinical Cancer Research.
[3] H. Wallerand,et al. N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors , 2006, Clinical Cancer Research.
[4] R. Weinberg,et al. Exploring a new twist on tumor metastasis. , 2006, Cancer research.
[5] A. Toker,et al. Akt signaling and cancer: surviving but not moving on. , 2006, Cancer research.
[6] J. Minna,et al. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. , 2006, Cancer research.
[7] I. Lascombe,et al. Expression of E-Cadherin and α-, β-, γ-Catenins in Patients With Bladder Cancer Identification of γ-Catenin as a New Prognostic Marker of Neoplastic Progression in T1 Superficial Urothelial Tumors , 2006 .
[8] J. Brugge,et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition , 2005, The Journal of cell biology.
[9] Avri Ben-Ze'ev,et al. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway , 2004, Oncogene.
[10] R. Hazan,et al. Cadherin Switch in Tumor Progression , 2004, Annals of the New York Academy of Sciences.
[11] S. Groshen,et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] K. Rieger-Christ,et al. Expression of classic cadherins type I in urothelial neoplastic progression. , 2001, Human pathology.
[13] C. Abbou,et al. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information , 2000, British Journal of Cancer.
[14] Stuart A. Aaronson,et al. Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.
[15] M. Namiki,et al. Dominant role of E-cadherin in the progression of bladder cancer. , 1999, The Journal of urology.
[16] Gerhard Christofori,et al. A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.
[17] R. Hazan,et al. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. , 1997, Cell adhesion and communication.
[18] R. Kerbel,et al. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells. , 1991, Cancer research.
[19] E. Messing,et al. Growth stimulating activity produced by human bladder cancer cells. , 1984, The Journal of urology.